Equativ Launches Media Planning Agent to Enhance Buyer Efficiency and Boost Campaign Outcomes
December 9, 2025
Built on Maestro by Equativ, this is the first of a full suite of Equativ AI Agents for buyers that
Category: MENA
Bitget Reports Record 4,468% Surge in Tokenized US Stock Futures During Earnings Season
December 9, 2025
Bitget Reports Record 4,468% Surge in Tokenized US Stock Futures During Earnings Season VICTORIA, Seychelles, Dec. 09, 2025 (GLOBE NEWSWIRE)
Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy
December 8, 2025
RICHARDSON, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — Mavenir, the software company building AI-by-design mobile networks, today announced a strong
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
December 8, 2025
REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and
Bitget October 2025 Protection Fund Maintains $741M Average Despite Slumptober
December 8, 2025
Bitget October 2025 Protection Fund Maintains $741M Average Despite Slumptober VICTORIA, Seychelles, Dec. 08, 2025 (GLOBE NEWSWIRE) — Bitget, the
EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025
December 8, 2025
Recognition follows a vote by professional and active traders, highlighting the critical role of execution quality in institutional-grade trading Best
Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows
December 8, 2025
LONDON, Dec. 08, 2025 (GLOBE NEWSWIRE) — A sharp acceleration in global wealth migration in 2025 is colliding with rapidly
Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting
December 8, 2025
DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma
Bitget Releases Major Upgrades to GetAgent With Smarter Responses and Free Access for All Users
December 5, 2025
Bitget Releases Major Upgrades to GetAgent With Smarter Responses and Free Access for All Users VICTORIA, Seychelles, Dec. 05, 2025
Moonup Technology Partners with European Smart Home Leader Shelly to Showcase Full Smart Building Ecosystem at the 2025 Taipei Building Show
December 5, 2025
Moonup Technology CEO Aaron Hsu TAIPEI, Taiwan, Dec. 04, 2025 (GLOBE NEWSWIRE) — Moonup Technology Co., Ltd., the Taiwan operations
Axi Attends Jeddah Fintech Week 2025, Showcases Their Products and Services
December 4, 2025
SYDNEY, Dec. 04, 2025 (GLOBE NEWSWIRE) — Axi, a financial leader in online CFD and FX trading, participated in Jeddah
CGTN: China-Europe Ties: Shaping the Next 50 Years
December 4, 2025
CGTN: China-Europe Ties: Shaping the Next 50 Years BEIJING, Dec. 04, 2025 (GLOBE NEWSWIRE) — This year marks the 50th
